DONNA BEAUMONT: Open Payments
NPI 1063431229 · ATHENS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 101 payments from 11 companies in 2025. Trend: 2023 $1,311 · 2024 $1,450 · 2025 $1,801
Food & beverage: $1,801
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $317 |
| ABBVIE INC. | 20 | $246 |
| Neurocrine BioSciences, Inc. | 8 | $158 |
| Axsome Therapeutics, Inc. | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 12 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| Alkermes, Inc. | 5 | $94 |
| Lundbeck LLC | 5 | $91 |
| Janssen Pharmaceuticals, Inc | 4 | $81 |
Products named: CAPLYTA, HETLIOZ, VRAYLAR, REXULTI, INGREZZA, Auvelity, TRINTELLIX, SPRAVATO.
Industry payments across OH — which companies pay providers there.
